Direct Access Expands Its Reach
Celent Communications forecasts strong growth in volumes for direct access providers, based upon increasing usage among institutions and continued market fragmentation.
In a new report, entitled , Celent examines the direct access marketplace, providing a brief history and analysis of current events in the industry and key benefits and features of the technology. The report also highlights different segments interested in the technology and the effect this interest will have overall.
The report predicts that direct access platforms will execute almost 500 billion shares annually by 2005, representing more than 35% of the total US equity marketplace.
Fritz McCormick, analyst at Celent and author of the report, "Direct access allows a trader to bring together market data into one book and execute upon that data, amalgamating liquidity and providing for best execution. The value of such a system for both retail and institutional traders is apparent; it enables greater efficiency and reduced trading costs. This functionality, combined with increasing market fragmentation, will help the technology continue to grow in usage."
A Table of Contents is available online.
of Celent Communications' Institutional and Retail Securities & Investments research services can download the report electronically by clicking on the icon to the left.
Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies. Celent publishes reports identifying trends and best practices in financial services technology and conducts consulting engagements for financial institutions looking to use technology to enhance existing business processes or launch new business strategies. With a team of internationally based analysts, Celent is uniquely positioned to offer strategic advice and market insights on a global basis. Celent is a member of the Oliver Wyman Group, which is a wholly-owned subsidiary of Marsh & McLennan Companies [NYSE: MMC].
Tel: +1 212 345 1366
Tel: +44 (0)782 448 3336
Tel.: +81 3 3500 3023
Table of Contents
|Boston, MA, USA May 16, 2002
Return to report Abstract